Orchestra BioMed
OBIO
OBIO
50 hedge funds and large institutions have $124M invested in Orchestra BioMed in 2021 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 9 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less capital invested
Capital invested by funds: $130M → $124M (-$6.6M)
Holders
50
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$3.06M | |
| 2 | +$2.61M | |
| 3 | +$2.55M | |
| 4 |
PMAM
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
|
+$802K |
| 5 |
AAA
Affinity Asset Advisors
New York
|
+$765K |
Top Sellers
| 1 | -$5.71M | |
| 2 | -$2.04M | |
| 3 | -$1.12M | |
| 4 |
SCM
Suvretta Capital Management
New York
|
-$560K |
| 5 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
-$539K |